|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Department of Obstetrics and Gynecology, School of Medicine, Yale University, New Haven, CT 06520;
Department of Biology and Environmental Science, University of New Haven, West Haven, CT 06516;
Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
The predominance of autoimmune diseases among women suggests that
estrogen may modulate immune function. Monocytes and macrophages are
important in initiating, maintaining, and resolving inflammatory
responses through cell-signaling molecules, which control immune cell
survival. One important mechanism of cell survival is mediated by the
Fas/Fas ligand (FasL) system. In this study, the link between estrogen,
monocytes/macrophages, and the Fas/FasL system was investigated.
Estrogen treatment increased FasL expression in monocytes through the
binding of the estrogen receptors (ER) to the estrogen recognizing
elements and AP-1 motifs present at the FasL promoter. Furthermore,
estrogen induced apoptosis in monocytes expressing ER
, but not in
monocyte-differentiated macrophages expressing ER
. The expression of
either ER
or ER
and their response to estrogen in monocytes was
found to be dependent on the their stage of cell differentiation.
Previously, we have shown that estrogen replacement therapy in
postmenopausal women decreased the number of circulating monocytes. In
this study, we have characterized the molecular mechanism by which
estrogen regulates monocytes homeostasis. These findings indicate that
estrogen may regulate immune cell survival through the Fas/FasL system.
There is biological relevance to these findings in view of studies
showing that accumulation of activated monocytes is involved in the
pathogenesis of conditions such as vasculititis, arteriosclerosis, and
rheumatoid arthritis.
This article has been cited by other articles:
![]() |
A. H. Beck, I. Espinosa, B. Edris, R. Li, K. Montgomery, S. Zhu, S. Varma, R. J. Marinelli, M. van de Rijn, and R. B. West The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma Clin. Cancer Res., February 1, 2009; 15(3): 778 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, R. Di Paola, T. Genovese, E. Mazzon, E. Esposito, C. Crisafulli, P. Bramanti, and D. Salvemini Anti-Inflammatory and Anti-Apoptotic Effects of Fumonisin B1, an Inhibitor of Ceramide Synthase, in a Rodent Model of Splanchnic Ischemia and Reperfusion Injury J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 45 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Abrahams, P. B. Aldo, S. P. Murphy, I. Visintin, K. Koga, G. Wilson, R. Romero, S. Sharma, and G. Mor TLR6 Modulates First Trimester Trophoblast Responses to Peptidoglycan J. Immunol., May 1, 2008; 180(9): 6035 - 6043. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Singh, V. L. Hegde, L. J. Hofseth, M. Nagarkatti, and P. Nagarkatti Resveratrol (trans-3,5,4'-Trihydroxystilbene) Ameliorates Experimental Allergic Encephalomyelitis, Primarily via Induction of Apoptosis in T Cells Involving Activation of Aryl Hydrocarbon Receptor and Estrogen Receptor Mol. Pharmacol., December 1, 2007; 72(6): 1508 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Brown, J. M. Davis, E. A. Murphy, M. D. Carmichael, J. A. Carson, A. Ghaffar, and E. P. Mayer Susceptibility to HSV-1 infection and exercise stress in female mice: role of estrogen J Appl Physiol, November 1, 2007; 103(5): 1592 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Pioli, A. L. Jensen, L. K. Weaver, E. Amiel, Z. Shen, L. Shen, C. R. Wira, and P. M. Guyre Estradiol Attenuates Lipopolysaccharide-Induced CXC Chemokine Ligand 8 Production by Human Peripheral Blood Monocytes J. Immunol., November 1, 2007; 179(9): 6284 - 6290. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Subramanian and C. Shaha Up-Regulation of Bcl-2 through ERK Phosphorylation Is Associated with Human Macrophage Survival in an Estrogen Microenvironment J. Immunol., August 15, 2007; 179(4): 2330 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Esposito, E. Mazzon, C. Muia, R. Meli, E. Sessa, and S. Cuzzocrea Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-{alpha} J. Leukoc. Biol., April 1, 2007; 81(4): 1032 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Robinson Anatomical and Hormonal Influences on Women's Dermatologic Health JAMA, March 22, 2006; 295(12): 1443 - 1445. [Full Text] [PDF] |
||||
![]() |
L. S. Ackerman Sex hormones and the genesis of autoimmunity. Arch Dermatol, March 1, 2006; 142(3): 371 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mao, V. Paharkova-Vatchkova, J. Hardy, M. M. Miller, and S. Kovats Estrogen Selectively Promotes the Differentiation of Dendritic Cells with Characteristics of Langerhans Cells J. Immunol., October 15, 2005; 175(8): 5146 - 5151. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Y. Han, J. J. Tarrand, R. Infante, K. L. Jacobson, and M. Truong Clinical Significance and Epidemiologic Analyses of Mycobacterium avium and Mycobacterium intracellulare among Patients without AIDS J. Clin. Microbiol., September 1, 2005; 43(9): 4407 - 4412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bouman, M. J. Heineman, and M. M. Faas Sex hormones and the immune response in humans Hum. Reprod. Update, July 1, 2005; 11(4): 411 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Soucy, G. Boivin, F. Labrie, and S. Rivest Estradiol Is Required for a Proper Immune Response to Bacterial and Viral Pathogens in the Female Brain J. Immunol., May 15, 2005; 174(10): 6391 - 6398. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Speyer, N. J. Rancilio, S. D. McClintock, J. D. Crawford, H. Gao, J. V. Sarma, and P. A. Ward Regulatory effects of estrogen on acute lung inflammation in mice Am J Physiol Cell Physiol, April 1, 2005; 288(4): C881 - C890. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Mishra and C. Shaha Estrogen-induced Spermatogenic Cell Apoptosis Occurs via the Mitochondrial Pathway: ROLE OF SUPEROXIDE AND NITRIC OXIDE J. Biol. Chem., February 18, 2005; 280(7): 6181 - 6196. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Chadwick, S. Chippari, E. Matelan, L. Borges-Marcucci, A. M. Eckert, J. C. Keith Jr., L. M. Albert, Y. Leathurby, H. A. Harris, R. A. Bhat, et al. Identification of pathway-selective estrogen receptor ligands that inhibit NF-{kappa}B transcriptional activity PNAS, February 15, 2005; 102(7): 2543 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Polanczyk, R. E. Jones, S. Subramanian, M. Afentoulis, C. Rich, M. Zakroczymski, P. Cooke, A. A. Vandenbark, and H. Offner T Lymphocytes Do Not Directly Mediate the Protective Effect of Estrogen on Experimental Autoimmune Encephalomyelitis Am. J. Pathol., December 1, 2004; 165(6): 2069 - 2077. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xiao, U. S. Deshmukh, S. Jodo, T. Koike, R. Sharma, A. Furusaki, S.-s. J. Sung, and S.-T. Ju Novel Negative Regulator of Expression in Fas Ligand (CD178) Cytoplasmic Tail: Evidence for Translational Regulation and against Fas Ligand Retention in Secretory Lysosomes J. Immunol., October 15, 2004; 173(8): 5095 - 5102. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bengtsson, E. J. Ryan, D. Giordano, D. M. Magaletti, and E. A. Clark 17{beta}-Estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells Blood, September 1, 2004; 104(5): 1404 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-x. Zhang, D. C. Labaree, G. Mor, and R. B. Hochberg Estrogen to Antiestrogen with a Single Methylene Group Resulting in an Unusual Steroidal Selective Estrogen Receptor Modulator J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3527 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, M. A. McKenna, X. Feng, T. R. Nagy, and J. M. McDonald Osteoclast Apoptosis: The Role of Fas in Vivo and in Vitro Endocrinology, December 1, 2003; 144(12): 5545 - 5555. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-J. Shim, L. Wang, S. Andersson, N. Nagy, L. L. Kis, Q. Zhang, S. Makela, M. Warner, and J.-A. Gustafsson Disruption of the estrogen receptor {beta} gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis PNAS, May 27, 2003; 100(11): 6694 - 6699. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |